Peers of Gilead Sciences, Inc. (GILD)
Health Care · Biotechnology
Enterprise value divided by EBITDA over the last 12 months. A common way to compare companies with different amounts of debt.
Latest EV/EBITDA
14.72x
As of Nov 2, 2026
Beyond EV/EBITDA, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/EBITDA |
|---|---|
| Nov 2, 2026 | 14.72x |
| Oct 30, 2026 | 14.75x |
| Oct 29, 2026 | 14.30x |
| Oct 28, 2026 | 13.73x |
| Oct 27, 2026 | 13.72x |
| Oct 26, 2026 | 13.68x |
| Oct 23, 2026 | 13.45x |
| Oct 22, 2026 | 13.55x |
EV/EBITDA = Enterprise Value / EBITDA (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/EBITDA is widely used because it removes the effects of financing and non-cash accounting items.
Read the general EV/EBITDA definition, formula, and analyst usage guide.
EV/EBITDA guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
